• News
  • SAN DIEGO
  • BioTech

Arena Pharma issued patent for chronic pain treatment

San Diego's Arena Pharmaceuticals Inc. (Nasdaq: ARNA) was granted U.S. Patent No. 8,778,950, entitled "Cannabinoid Receptor Modulators," by the U.S. Patent and Trademark Office for APD371, an agonist of the cannabinoid receptor 2 (CB2).

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Arena Pharmaceuticals Inc.

Company Website

6166 Nancy Ridge Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ARNA
4.19
  -0.06  
- 1.41%
4,798,494,000
7.97
3.82

Insider Trade Data

Date Insider Shares Type Value
09/17/2014 Lief, Jack 100,000 Exchange $149,000
07/01/2014 Lief, Jack 223,525 Sell $1,308,582
06/27/2014 Belcher, Donald D 2,473 Sell $14,467
06/27/2014 Belcher, Donald D 2,473 Exchange $13,503
06/27/2014 Belcher, Donald D 2,473 Exchange $13,503

Arena Pharmaceuticals Inc. Executive(s):

Jack Lief

  • Chief Executive Officer, President, Chairman

Similar Companies

NAICS - 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
SIC - 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
Subscribe Today!